Pharmacokinetic Interaction Between BIA 9-1067 and Standard-release Levodopa/Carbidopa in Healthy Subjects.
Latest Information Update: 15 Jun 2023
At a glance
- Drugs Levodopa/carbidopa (Primary) ; Opicapone (Primary)
- Indications Parkinson's disease
- Focus Pharmacokinetics
- 27 Apr 2023 Results of pooled post-hoc analysis included data from 2 open-label Phase 1 studies (NCT01533077and NCT03496870 presented at the 75th Annual Meeting of the American Academy of Neurology 2023.
- 18 Sep 2022 Results of post-hoc analysis included data from 2 open-label Phase 1 studies (NCT01533077and NCT03496870), presented at the 26th International Congress of Parkinson's Disease and Movement Disorders.
- 20 Jun 2012 Primary endpoint amneded as reported by ClinicalTrials.gov.